1. Home
  2. RXRX vs DFIN Comparison

RXRX vs DFIN Comparison

Compare RXRX & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

SELL

Current Price

$4.71

Market Cap

2.2B

Sector

Health Care

ML Signal

SELL

Logo Donnelley Financial Solutions Inc.

DFIN

Donnelley Financial Solutions Inc.

HOLD

Current Price

$48.09

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXRX
DFIN
Founded
2013
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.2B
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
RXRX
DFIN
Price
$4.71
$48.09
Analyst Decision
Buy
Buy
Analyst Count
7
3
Target Price
$7.22
★ $64.00
AVG Volume (30 Days)
★ 16.4M
170.1K
Earning Date
11-04-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 14.79
N/A
EPS
N/A
★ 2.72
Revenue
$74,681,000.00
★ $963,000,000.00
Revenue This Year
N/A
$1.83
Revenue Next Year
$34.96
$3.56
P/E Ratio
★ N/A
$17.46
Revenue Growth
★ 26.92
N/A
52 Week Low
$2.77
$36.11
52 Week High
$7.18
$56.26

Technical Indicators

Market Signals
Indicator
RXRX
DFIN
Relative Strength Index (RSI) 72.16 50.54
Support Level $2.90 $45.76
Resistance Level $5.12 $50.56
Average True Range (ATR) 0.27 1.39
MACD 0.08 -0.11
Stochastic Oscillator 93.11 61.71

Price Performance

Historical Comparison
RXRX
DFIN

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a risk and compliance software solutions and related services provider. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. It operates in four reportable segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management (its key revenue-generating segment), Investment Companies - Software Solutions, and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States (USA), Europe, Asia, Canada, and Others, of which the USA accounts for the vast majority of its total revenue.

Share on Social Networks: